Compare $LSTA vs $XCUR | Chartloom

Compare

$LSTA vs $XCUR

Lisata Therapeutics Inc · Exicure Inc

LSTA

Lisata Therapeutics Inc

XCUR

Exicure Inc

Compare $LSTA vs $XCUR

Comparing Lisata Therapeutics Inc and Exicure Inc

LSTALisata Therapeutics Inc

XCURExicure Inc

LSTALisata Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-90.7%

YTD performance

-45.9%

52W performance

-58.1%

FCF yield

-127.6%

XCURExicure Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-80.3%

FCF yield

-105.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LSTA

XCUR

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

XCUR

Exicure Inc

Market Cap

LSTA$10M

XCUR$7M

Enterprise Value

LSTA$-786K

XCUR$5M

Price

LSTA$1.06

XCUR$1.05

P/E Ratio

LSTAN/A

XCURN/A

P/S Ratio

LSTA96.57x

XCUR14.24x

EV/Sales

LSTA-7.86x

XCUR10.81x

EV/EBITDA

LSTA0.00x

XCUR0.90x

P/B Ratio

LSTA1.61x

XCUR7.29x

P/FCF Ratio

LSTAN/A

XCURN/A

EV/FCF

LSTA0.06x

XCUR-0.71x

PEG Ratio

LSTAN/A

XCURN/A

Forward P/E (NTM)

LSTAN/A

XCURN/A

Forward P/S (NTM)

LSTAN/A

XCURN/A

Revenue (TTM)

LSTA$100K

XCUR$0

Revenue Growth (YoY)

LSTA-90.7%

XCURN/A

Forward Rev Growth

LSTA44.0%

XCUR0.0%

Gross Margin (TTM)

LSTA9.5%

XCUR0.0%

Operating Margin (TTM)

LSTA0.0%

XCUR0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

XCUR0.0%

Net Margin (TTM)

LSTA-10132.0%

XCUR0.0%

FCF Margin (TTM)

LSTA-12323.0%

XCURN/A

Net Income (TTM)

LSTA$-10M

XCUR$-8M

FCF (TTM)

LSTA$-12M

XCUR$-7M

EPS (TTM)

LSTA-$1.11

XCUR-$1.30

ROE (TTM)

LSTA-7510.0%

XCUR-23791.0%

ROA (TTM)

LSTA-6015.0%

XCUR-6198.0%

ROIC (TTM)

LSTA-7510.0%

XCUR-23791.0%

Cash

LSTA$10M

XCUR$2M

Debt

LSTA$0

XCUR$0

Net Cash/Debt

LSTA$10M

XCUR$2M

Current Ratio (TTM)

LSTA3.69x

XCUR0.56x

Quick Ratio (TTM)

LSTA3.50x

XCUR0.43x

Debt/Equity (TTM)

LSTA0.00x

XCUR0.00x

Debt/Assets (TTM)

LSTA0.0%

XCUR0.0%

Interest Coverage (TTM)

LSTAN/A

XCURN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

XCUR0.00x

Beta

LSTA0.97

XCUR3.86

52W Performance

LSTA-58.1%

XCUR-80.3%

YTD Performance

LSTA-45.9%

XCUR-81.2%

% from 52W High

LSTA-79.1%

XCUR-88.9%

% from 52W Low

LSTA7.3%

XCUR12.2%

Asset Turnover (TTM)

LSTA0.01x

XCUR0.05x

FCF Yield (TTM)

LSTA-127.6%

XCUR-105.0%

Earnings Yield (TTM)

LSTA-104.9%

XCUR-123.9%

Dividend Yield (TTM)

LSTAN/A

XCURN/A

Rule of 40

LSTA-12,413.7

XCUR0.0

EV/GP/RG

LSTAN/A

XCURN/A

Ticker research

View LSTA research View XCUR research

Metric	LSTA Lisata Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$-786K	$5M
Price	$1.06	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	14.24x
EV/Sales	-7.86x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	1.61x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	0.0%
Profitability
Gross Margin (TTM)	9.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	0.0%
Net Margin (TTM)	-10132.0%	0.0%
FCF Margin (TTM)	-12323.0%	N/A
Net Income (TTM)	$-10M	$-8M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$1.11	-$1.30
ROE (TTM)	-7510.0%	-23791.0%
ROA (TTM)	-6015.0%	-6198.0%
ROIC (TTM)	-7510.0%	-23791.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$0
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	3.69x	0.56x
Quick Ratio (TTM)	3.50x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	3.86
52W Performance	-58.1%	-80.3%
YTD Performance	-45.9%	-81.2%
% from 52W High	-79.1%	-88.9%
% from 52W Low	7.3%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-127.6%	-105.0%
Earnings Yield (TTM)	-104.9%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LSTA research	View XCUR research

Valuation

P/S Ratio

XCUR

14.24x

LSTA

96.57x

EV/FCF

XCUR

-0.71x

LSTA

0.06x

Growth & revenue

Revenue Growth TTM

LSTA

-90.7%

Forward Revenue Growth

LSTA

44.0%

XCUR

0.0%

Profitability & performance

Gross Margin

LSTA

9.5%

XCUR

0.0%

ROE

LSTA

-7510.0%

XCUR

-23791.0%

FCF Yield %

XCUR

-105.0%

LSTA

-127.6%

52-Week Performance

LSTA

-58.1%

XCUR

-80.3%

Detailed metrics comparison

LSTA

Lisata Therapeutics Inc

XCUR

Exicure Inc

Market Cap

LSTA$10M

XCUR$7M

Enterprise Value

LSTA$-786K

XCUR$5M

Price

LSTA$1.06

XCUR$1.05

P/E Ratio

LSTAN/A

XCURN/A

P/S Ratio

LSTA96.57x

XCUR14.24x

EV/Sales

LSTA-7.86x

XCUR10.81x

EV/EBITDA

LSTA0.00x

XCUR0.90x

P/B Ratio

LSTA1.61x

XCUR7.29x

P/FCF Ratio

LSTAN/A

XCURN/A

EV/FCF

LSTA0.06x

XCUR-0.71x

PEG Ratio

LSTAN/A

XCURN/A

Forward P/E (NTM)

LSTAN/A

XCURN/A

Forward P/S (NTM)

LSTAN/A

XCURN/A

Revenue (TTM)

LSTA$100K

XCUR$0

Revenue Growth (YoY)

LSTA-90.7%

XCURN/A

Forward Rev Growth

LSTA44.0%

XCUR0.0%

Gross Margin (TTM)

LSTA9.5%

XCUR0.0%

Operating Margin (TTM)

LSTA0.0%

XCUR0.0%

EBITDA Margin (TTM)

LSTA-11423.0%

XCUR0.0%

Net Margin (TTM)

LSTA-10132.0%

XCUR0.0%

FCF Margin (TTM)

LSTA-12323.0%

XCURN/A

Net Income (TTM)

LSTA$-10M

XCUR$-8M

FCF (TTM)

LSTA$-12M

XCUR$-7M

EPS (TTM)

LSTA-$1.11

XCUR-$1.30

ROE (TTM)

LSTA-7510.0%

XCUR-23791.0%

ROA (TTM)

LSTA-6015.0%

XCUR-6198.0%

ROIC (TTM)

LSTA-7510.0%

XCUR-23791.0%

Cash

LSTA$10M

XCUR$2M

Debt

LSTA$0

XCUR$0

Net Cash/Debt

LSTA$10M

XCUR$2M

Current Ratio (TTM)

LSTA3.69x

XCUR0.56x

Quick Ratio (TTM)

LSTA3.50x

XCUR0.43x

Debt/Equity (TTM)

LSTA0.00x

XCUR0.00x

Debt/Assets (TTM)

LSTA0.0%

XCUR0.0%

Interest Coverage (TTM)

LSTAN/A

XCURN/A

Net Debt/EBITDA (TTM)

LSTA0.00x

XCUR0.00x

Beta

LSTA0.97

XCUR3.86

52W Performance

LSTA-58.1%

XCUR-80.3%

YTD Performance

LSTA-45.9%

XCUR-81.2%

% from 52W High

LSTA-79.1%

XCUR-88.9%

% from 52W Low

LSTA7.3%

XCUR12.2%

Asset Turnover (TTM)

LSTA0.01x

XCUR0.05x

FCF Yield (TTM)

LSTA-127.6%

XCUR-105.0%

Earnings Yield (TTM)

LSTA-104.9%

XCUR-123.9%

Dividend Yield (TTM)

LSTAN/A

XCURN/A

Rule of 40

LSTA-12,413.7

XCUR0.0

EV/GP/RG

LSTAN/A

XCURN/A

Ticker research

View LSTA research View XCUR research

Metric	LSTA Lisata Therapeutics Inc	XCUR Exicure Inc
Market & Valuation
Market Cap	$10M	$7M
Enterprise Value	$-786K	$5M
Price	$1.06	$1.05
P/E Ratio	N/A	N/A
P/S Ratio	96.57x	14.24x
EV/Sales	-7.86x	10.81x
EV/EBITDA	0.00x	0.90x
P/B Ratio	1.61x	7.29x
P/FCF Ratio	N/A	N/A
EV/FCF	0.06x	-0.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-90.7%	N/A
Forward Rev Growth	44.0%	0.0%
Profitability
Gross Margin (TTM)	9.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-11423.0%	0.0%
Net Margin (TTM)	-10132.0%	0.0%
FCF Margin (TTM)	-12323.0%	N/A
Net Income (TTM)	$-10M	$-8M
FCF (TTM)	$-12M	$-7M
EPS (TTM)	-$1.11	-$1.30
ROE (TTM)	-7510.0%	-23791.0%
ROA (TTM)	-6015.0%	-6198.0%
ROIC (TTM)	-7510.0%	-23791.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$0
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	3.69x	0.56x
Quick Ratio (TTM)	3.50x	0.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	3.86
52W Performance	-58.1%	-80.3%
YTD Performance	-45.9%	-81.2%
% from 52W High	-79.1%	-88.9%
% from 52W Low	7.3%	12.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-127.6%	-105.0%
Earnings Yield (TTM)	-104.9%	-123.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-12,413.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View LSTA research	View XCUR research